Skip to main content
Relapsed CLL: New approaches prolong survival
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Relapsed CLL: New approaches prolong survival
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Biologic Therapy
0
0.99
Tyrosine Kinase Inhibitor
0
0.94
Tyrosine Kinase
0
0.71
Patient Safety
0
0.2
Remission
0
0.18
Residual Disease
0
0.18
Atrial Fibrillation
0
0.13
Adverse Effects
0
0.09
Cancer
0
0.09
Chimera
0
0.09
Hospital
0
0.09
Kidney
0
0.09
Leukemia
0
0.09
New York
0
0.09
Specialty
Lead
score
Hematology-Oncology
1
1
Edit Tags